EXELIXIS, INC. — Director's Dealing 2017

Sep 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2017-09-18

Reporting Person: PAPADOPOULOS STELIOS (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-18	Common Stock	S	72210	$27.76	Disposed	1162104	Direct
2017-09-19	Common Stock	S	127790	$27.63	Disposed	1034314	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Indirect

Footnotes

F1: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $27.74 to $27.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder ofExelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to thisForm 4

F2: Includes 5,843 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F3: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $27.60 to $27.73. Reporting Person undertakes to provide Exelixis, Inc., any security holder ofExelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to thisForm 4

F4: Shares are held by Fondation Sante, of which the Reporting Person is co-trustee.